ketanserin (Compound)

Synonyms:Ketanserin, 74050-98-9, Ketanserin tartrate, Ketanserinum, Ketaserin, Ketanserina, Ketanserine, 3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1H,3H)-dione, R-41468, R-41,468

Pubchem:PUBCHEM:3822

Id:efddf75d-a029-5afd-af8c-7524e4bdd43a

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ketanserin's neighborhood in the knowledge graph.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ketanserin.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ketanserin.

Results found

Linked to

	Label	Description
	BRD-K49671696-001-05-4 Substance (Entity type)	A Substance
	ketanserin positively regulates ARNT2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ketanserin negatively regulates S100P Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ketanserin negatively regulates RPS4Y1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ketanserin positively regulates LPCAT1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ketanserin negatively regulates CEACAM6 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	DCSTRUCT ID 01524 Collection (Entity type)	DrugPage Collection: (DrugCentralID:01524; PubChem_CID:3822, FILE=drugcentral_drug_01524.json)
	ketanserin bioactivity 5-hydroxytryptamine receptor 2B Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	ketanserin negatively regulates PLBD1 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS
	ketanserin positively regulates ATP6V1D Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from LINCS

BRD-K49671696-001-05-4

Substance (Entity type)

A Substance

ketanserin positively regulates ARNT2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

ketanserin negatively regulates S100P

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

ketanserin negatively regulates RPS4Y1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

ketanserin positively regulates LPCAT1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

ketanserin negatively regulates CEACAM6

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DCSTRUCT ID 01524

Collection (Entity type)

DrugPage Collection: (DrugCentralID:01524; PubChem_CID:3822, FILE=drugcentral_drug_01524.json)

ketanserin bioactivity 5-hydroxytryptamine receptor 2B

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

ketanserin negatively regulates PLBD1

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

ketanserin positively regulates ATP6V1D

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.